How reproducible are data-driven subtypes of Alzheimer's disease atrophy?
Journal of Alzheimer’s Disease · 2026
DOI: 10.1177/13872877251415019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2026. Verfasst von Emma Prevot und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics and Biomedical Engineering, University College London, Gower Street, London, UK. Hauptthemen laut MEDLINE: Alzheimer Disease, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: UKRI Medical Research Council.
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer's disease (AD) exhibits substantial clinical and biological heterogeneity, complicating efforts in treatment and intervention development. While new computational methods offer insights into AD subtyping and disease staging, the reproducibility of these subtypes across datasets remains understudied, particularly concerning the robustness of subtype definitions when validated on diverse databases.
Objective
This study evaluates the robustness of the AD progression subtypes identified by the Subtype and Stage Inference (SuStaIn) algorithm on a larger and more diverse cohort.
Methods
We extracted T1-weighted MRI data for 5444 subjects from ANMerge, OASIS, and ADNI datasets, forming four independent cohorts. Each cohort was analyzed with SuStaIn under two conditions: one using the full cohort, including cognitively normal controls, and another excluding controls to test subtype robustness.
Results
Results confirm the three primary atrophy subtypes identified in earlier studies: Typical, Cortical, and Subcortical, as well as the emergence of rare and atypical AD variants such as posterior cortical atrophy. Notably, each subtype displayed varying robustness to the inclusion of controls, with certain subtypes, like the Subcortical subtype, more influenced by cohort composition.
Conclusions
This investigation underscores SuStaIn's reliability for defining stable AD subtypes and suggests its utility in clinical stratification for trials and diagnosis. However, our findings also highlight the need for improved dataset ethnic and demographic diversity, particularly in terms of ethnic representation, to enhance generalizability and support broader clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Physics and Biomedical Engineering, University College London, Gower Street, London, UK.
- UCL Hawkes Institute and Department of Computer Science, University College London, Gower Street, London, UK.
ORCID-Profile: Emma Prevot, Cameron Shand, Neil Oxtoby
Förderung
- UKRI Medical Research Council
Zitieren
APA
Prevot, E., Shand, C., for Alzheimer’s Disease Neuroimaging Initiative, & Oxtoby, N. (2026). How reproducible are data-driven subtypes of Alzheimer's disease atrophy?. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251415019
Vancouver
Prevot E, Shand C, for Alzheimer’s Disease Neuroimaging Initiative, Oxtoby N. How reproducible are data-driven subtypes of Alzheimer's disease atrophy?. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877251415019
BibTeX
@article{Prevot2026,
author = {Prevot, Emma and Shand, Cameron and for Alzheimer’s Disease Neuroimaging Initiative, for Alzheimer’s Disease Neuroimaging Initiative and Oxtoby, Neil},
title = {How reproducible are data-driven subtypes of Alzheimer's disease atrophy?},
journal = {Journal of Alzheimer’s Disease},
year = {2026},
doi = {10.1177/13872877251415019}
}
EUVIMED